Brown, Janet ; Royle, Kara-Louise ; Gregory, Walter...
Brown , J , Royle , K-L , Gregory , W , Ralph , C , Maraveyas , A , Din , O , Eisen , T , Nathan , P , Powles , T , Griffiths , R , Jones , R , Vasudev , N , Wheater , M , Hamid , A , Waddell , T , McMenemin , R , Patel , P , Larkin , J , Faust , G , Martin , A , Swain , J , Bestall , J , McCabe , C , Meads , D , Goh , V , Wah , T M , Brown , J , Hewison , J , Selby , P & Collinson , F 2023 , ' Temporary treatment cessation versus continuation of first-line tyrosine kinase inhibitor in patients with advanced clear cell renal cell carcinoma (STAR): an open-label, non-inferiority, randomised, controlled, phase 2/3 trial ' , The Lancet Oncology , vol. 24 , no. 3 , pp. 213-227 . https://doi.org/10.1016/S1470-2045(22)00793-8.  , 2023

Brown, Janet E ; Royle, Kara-Louise ; Gregory, Walter...
STAR Investigators , Brown , J E , Royle , K-L , Gregory , W , Ralph , C , Maraveyas , A , Din , O , Eisen , T , Nathan , P , Powles , T , Griffiths , R , Jones , R , Vasudev , N , Wheater , M , Hamid , A , Waddell , T , McMenemin , R , Patel , P , Larkin , J , Faust , G , Martin , A , Swain , J , Bestall , J , McCabe , C , Meads , D , Goh , V , Min Wah , T , Brown , J , Hewison , J , Selby , P & Collinson , F 2023 , ' Temporary treatment cessation versus continuation of first-line tyrosine kinase inhibitor in patients with advanced clear cell renal cell carcinoma (STAR): an open-label, non-inferiority, randomised, controlled, phase 2/3 trial ' , Lancet Oncology , vol. 24 , no. 3 , pp. 213-227 . https://doi.org/10.1016/S1470-2045(22)00793-8.  , 2023